Indel Pharmaceuticals Private Limited
About Indel Pharmaceuticals Private Limited
Data last updated:
Indel Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 03 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC251577. Its GSTIN is 07AADCI2242N1ZI (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chander Kanta and Nidhi Sahrawat.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at House No – 522 Village Daryapur, New Delhi, Delhi, India – 110039.
As per the financials filed for FY 2019, the company reported a revenue of ₹5.23 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹2.08 Lakh (net margin -39.9%) and EBITDA of -₹2.04 Lakh (EBITDA margin -39.1%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No – 522 Village Daryapur, New Delhi, Delhi, India – 110039
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Indel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Indel Pharmaceuticals Private Limited
FY 2019 filings availableIndel Pharmaceuticals Private Limited reported revenue of ₹5.23 Lakh (down 35% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over three years, including a 35% fall in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2014-15 to FY 2017-18in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹2.04 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹2.08 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2018-19 | FY 2014-15 to FY 2017-18in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -39.1% | |
| Net Profit Margin | -39.9% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2014-15 to FY 2017-18, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indel Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Indel Pharmaceuticals Private Limited
Indel Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chander Kanta | Director | 03 May 2013 | 13 Years 5 Months | Current |
| Nidhi Sahrawat | Director | 18 Apr 2015 | 11 Years 6 Months | Current |
Peer Comparison
Indel Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Starcia Pharmaceuticals Private Limited | ₹5.25 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Surat, Gujarat, India |
| Scinder Pharmaceuticals Private Limited | ₹5.24 Lakh (FY 2023) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| Indel Pharmaceuticals Private Limited this company | ₹5.23 Lakh (FY 2019) | •••• | •••• | -35.0% | •••• | New Delhi, Delhi, India |
| Better Aid Pharmaceuticals Private Limited | ₹5.2 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Madsmed Pharmaceuticals Private Limited | ₹5.19 Lakh (FY 2019) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Fragrance Pharmaceuticals Private Limited | ₹5.18 Lakh (FY 2022) | •••• | •••• | -67.0% | •••• | Vadodara, Gujarat, India |
Peers are the companies nearest to Indel Pharmaceuticals by revenue, above and below it, in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Indel Pharmaceuticals Private Limited is audited by ADISHJAIN for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ADISHJAIN | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Indel Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases
Indel Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (L I R) | Filed against the company by individuals | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Indel Pharmaceuticals.
: available in the company report
Recent Activity
Indel Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Manish Sahrawat ceased to be Director on 25 Nov 2017.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Indel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCI2242N1ZI | Delhi | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Indel Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 03 May 2013 (13+ years old) and is registered under CIN U85100DL2013PTC251577.
Indel Pharmaceuticals has 2 current directors:
- Chander Kanta - Director
- Nidhi Sahrawat - Director
The latest financial statements of Indel Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Indel Pharmaceuticals is 07AADCI2242N1ZI, registered in Delhi.
The CIN (Corporate Identification Number) of Indel Pharmaceuticals is U85100DL2013PTC251577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indel Pharmaceuticals has 2 court cases on record: 2 filed against it.
Indel Pharmaceuticals was incorporated on 03 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Indel Pharmaceuticals by revenue are Starcia Pharmaceuticals Private Limited, Scinder Pharmaceuticals Private Limited, Better Aid Pharmaceuticals Private Limited, Madsmed Pharmaceuticals Private Limited, Fragrance Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manish Sahrawat ceased to be Director on 25 Nov 2017. Nidhi Sahrawat was appointed as Director on 18 Apr 2015. Rupa Ashokbhai Arora ceased to be Director on 17 Jan 2015. Indel Pharmaceuticals has 4 board changes on record in total.
The registered office of Indel Pharmaceuticals is at House No – 522 Village Daryapur, New Delhi, Delhi, India – 110039.
Indel Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.